Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.

[1]  K. Okumura,et al.  Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. , 2002, Atherosclerosis.

[2]  S. Yokoyama,et al.  Erratum to “Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography”: [Atherosclerosis 159 (2001) 153–163] , 2002 .

[3]  S. Yokoyama,et al.  Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. , 2001, Atherosclerosis.

[4]  S. Yamashita,et al.  Point Mutation (−69 G→A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  T. Saruta,et al.  Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. , 2001, Atherosclerosis.

[6]  A. von Eckardstein,et al.  High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[8]  P. Barter.  CETP and atherosclerosis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[9]  G. Luc,et al.  Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. , 2000, Atherosclerosis.

[10]  P. Talmud,et al.  Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter. , 2000, Circulation.

[11]  P. Wilson,et al.  Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[12]  F. Cambien,et al.  New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  V. Gudnason,et al.  Cholesteryl ester transfer protein gene effect on CETP activity and plasma high‐density lipoprotein in European populations , 1999, European journal of clinical investigation.

[14]  H. Suzuki,et al.  A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. , 1998, Preventive medicine.

[15]  N. Rifai,et al.  Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method. , 1998, Clinical chemistry.

[16]  J W Jukema,et al.  The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. , 1998, The New England journal of medicine.

[17]  M. Elchebly,et al.  Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. , 1998, Journal of lipid research.

[18]  S. Yamashita,et al.  Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Boer,et al.  Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[20]  B. Föger,et al.  Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Y. Ozaki,et al.  CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese. , 1996, Atherosclerosis.

[22]  D. Rader,et al.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. , 1995, The Journal of clinical investigation.

[23]  D. Arveiler,et al.  Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. , 1995, The Journal of clinical investigation.

[24]  K. Uekama,et al.  Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. , 1995, Clinical chemistry.

[25]  E. Boerwinkle,et al.  Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. , 1995, Human molecular genetics.

[26]  A. Tall,et al.  Plasma cholesteryl ester transfer protein and high‐density lipoproteins: new insights from molecular genetic studies , 1995, Journal of internal medicine.

[27]  H. Mabuchi,et al.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. , 1994, The Journal of clinical investigation.

[28]  D. Rader,et al.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. , 1993, The Journal of clinical investigation.

[29]  S. Yamashita,et al.  Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia. , 1993, Atherosclerosis.

[30]  S. Yamashita,et al.  Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. , 1991, Metabolism: clinical and experimental.

[31]  A. Tall,et al.  Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. , 1991, The Journal of clinical investigation.

[32]  A. Tall,et al.  Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. , 1990, The Journal of clinical investigation.

[33]  R. Lawn,et al.  DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels , 1989, Clinical genetics.

[34]  S. Yamashita,et al.  Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. , 1988, Atherosclerosis.

[35]  H. Itakura,et al.  New substrate for determination of serum lecithin:cholesterol acyltransferase. , 1987, Journal of lipid research.

[36]  N. Rifai,et al.  Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. , 1986, Clinical chemistry.

[37]  H. Mabuchi,et al.  Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. , 1985, Atherosclerosis.

[38]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.